The SAT1 flipper, an optimized tool for gene disruption in Candida albicans

Gene

Volumn 341, Issue 1-2, 2004, Pages 119-127

  Reuß, Oliver ^a   Vik, Åshild ^b   Kolter, Roberto ^b   Morschhäuser, Joachim ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

base pairs; bp; C; Candida; Dominant selection marker; ECL; enhanced chemiluminescence; Eth; ethionine; FLP recombination target; FRT; Homozygous mutants; kb; Marker recycling; Nourseothricin resistance; Oligopeptide transporter; Targeted gene disruption

Indexed keywords

FUNGAL ENZYME; NOURSEOTHRICIN; PEPTIDE TRANSPORTER 1; RECOMBINASE; STREPTOTHRICIN ACETYLTRANSFERASE 1; UNCLASSIFIED DRUG;

ARTICLE; CANDIDA ALBICANS; DNA FLANKING REGION; FUNGAL GENE; FUNGAL GENETICS; FUNGAL STRAIN; FUNGUS MUTANT; GENE CASSETTE; GENE DISRUPTION; GENE IDENTIFICATION; GENE SEQUENCE; GENE TARGETING; GENETIC ANALYSIS; GENETIC RESISTANCE; GENOME; MICROBIAL SENSITIVITY TEST; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STREPTOTHRICIN ACETYLTRANSFERASE 1 GENE; WILD TYPE;

CANDIDA ALBICANS; CELL DIVISION; DNA NUCLEOTIDYLTRANSFERASES; FUNGAL PROTEINS; GENE TARGETING; GENETIC MARKERS; GENOTYPE; MEMBRANE TRANSPORT PROTEINS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, INSERTIONAL; MUTATION; PLASMIDS; TRANSFORMATION, GENETIC;

CANDIDA; CANDIDA ALBICANS;

EID: 5044225522     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2004.06.021     Document Type: Article

References (33)

1. Backen A.C., Broadbent I.D., Fetherston R.W., Rosamond J.D., Schnell N.F., Stark M.J. Evaluation of the CaMAL2 promoter for regulated expression of genes in Candida albicans. Yeast. 16:2000;1121-1129
2. Bain J.M., Stubberfield C., Gow N.A. Ura-status-dependent adhesion of Candida albicans mutants. FEMS Microbiol. Lett. 204:2001;323-328
3. Cheng S., Nguyen M.H., Zhang Z., Jia H., Handfield M., Clancy C.J. Evaluation of the roles of four Candida albicans genes in virulence by using gene disruption strains that express URA3 from the native locus. Infect. Immun. 71:2003;6101-6103
4. Cole M.F., Bowen W.H., Zhao X.J., Cihlar R.L. Avirulence of Candida albicans auxotrophic mutants in a rat model of oropharyngeal candidiasis. FEMS Microbiol. Lett. 126:1995;177-180
5. Fonzi W.A., Irwin M.Y. Isogenic strain construction and gene mapping in Candida albicans. Genetics. 134:1993;717-728
6. Garraway L.A., Tosi L.R., Wang Y., Moore J.B., Dobson D.E., Beverley S.M. Insertional mutagenesis by a modified in vitro Ty1 transposition system. Gene. 198:1997;27-35
7. Gillum A.M., Tsay E.Y., Kirsch D.R. Isolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol. Gen. Genet. 198:1984;179-182
8. Heim U., Tietze E., Weschke W., Tschäpe H., Wobus U. Nucleotide sequence of a plasmid born streptothricin-acetyl-transferase gene (sat-1). Nucleic Acids Res. 17:1989;7103
9. Hube B., Monod M., Schofield D.A., Brown A.J., Gow N.A. Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans. Mol. Microbiol. 14:1994;87-99
10. Hube B., Sanglard D., Odds F.C., Hess D., Monod M., Schafer W., Brown A.J., Gow N.A. Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence. Infect. Immun. 65:1997;3529-3538
11. Joshi P.B., Webb J.R., Davies J.E., McMaster W.R. The gene encoding streptothricin acetyltransferase (sat) as a selectable marker for Leishmania expression vectors. Gene. 156:1995;145-149
12. Kirsch D.R., Whitney R.R. Pathogenicity of Candida albicans auxotrophic mutants in experimental infections. Infect. Immun. 59:1991;3297-3300
13. Köhler G.A., White T.C., Agabian N. Overexpression of a cloned IMP dehydrogenase gene of Candida albicans confers resistance to the specific inhibitor mycophenolic acid. J. Bacteriol. 179:1997;2331-2338
14. Krügel H., Fiedler G., Haupt I., Sarfert E., Simon H. Analysis of the nourseothricin-resistance gene (nat) of Streptomyces noursei. Gene. 62:1988;209-217
15. Lay J., Henry L.K., Clifford J., Koltin Y., Bulawa C.E., Becker J.M. Altered expression of selectable marker URA3 in gene-disrupted Candida albicans strains complicates interpretation of virulence studies. Infect. Immun. 66:1998;5301-5306
16. Lerner C.G., Goldman R.C. Stimuli that induce production of Candida albicans extracellular aspartyl proteinase. J. Gen. Microbiol. 139(Pt. 7):1993;1643-1651
17. Lubkowitz M.A., Hauser L., Breslav M., Naider F., Becker J.M. An oligopeptide transport gene from Candida albicans. Microbiology. 143(Pt. 2):1997;387-396
18. Moran G., Sullivan D., Morschhäuser J., Coleman D. The Candida dubliniensis CdCDR1 gene is not essential for fluconazole resistance. Antimicrob. Agents Chemother. 46:2002;2829-2841
19. Naglik J.R., Challacombe S.J., Hube B. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol. Mol. Biol. Rev. 67:2003;400-428. (table of contents)
20. Norrander J., Kempe T., Messing J. Construction of improved M13 vectors using oligodeoxynucleotide-directed mutagenesis. Gene. 26:1983;101-106
21. Roemer T., Jiang B., Davison J., Ketela T., Veillette K., Breton A., Tandia F., Linteau A., Sillaots S., Marta C., Martel N., Veronneau S., Lemieux S., Kauffman S., Becker J., Storms R., Boone C., Bussey H. Large-scale essential gene identification in Candida albicans and applications to antifungal drug discovery. Mol. Microbiol. 50:2003;167-181
22. Sanchez-Martinez C., Perez-Martin J. Site-specific targeting of exogenous DNA into the genome of Candida albicans using the FLP recombinase. Mol. Genet. Genomics. 268:2002;418-424
23. Santos M.A., Tuite M.F. The CUG codon is decoded in vivo as serine and not leucine in Candida albicans. Nucleic Acids Res. 23:1995;1481-1486
24. Staab J.F., Sundstrom P. URA3 as a selectable marker for disruption and virulence assessment of Candida albicans genes. Trends Microbiol. 11:2003;69-73
25. Staib P., Kretschmar M., Nichterlein T., Hof H., Morschhäuser J. Differential activation of a Candida albicans virulence gene family during infection. Proc. Natl. Acad. Sci. U. S. A. 97:2000;6102-6107
26. Staib P., Moran G.P., Sullivan D.J., Coleman D.C., Morschhäuser J. Isogenic strain construction and gene targeting in Candida dubliniensis. J. Bacteriol. 183:2001;2859-2865
27. Staib P., Kretschmar M., Nichterlein T., Hof H., Morschhäuser J. Host versus in vitro signals and intrastrain allelic differences in the expression of a Candida albicans virulence gene. Mol. Microbiol. 44:2002;1351-1366
28. Strauß A., Michel S., Morschhäuser J. Analysis of phase-specific gene expression at the single-cell level in the white-opaque switching system of Candida albicans. J. Bacteriol. 183:2001;3761-3769
29. Sundstrom P., Cutler J.E., Staab J.F. Reevaluation of the role of HWP1 in systemic candidiasis by use of Candida albicans strains with selectable marker URA3 targeted to the ENO1 locus. Infect. Immun. 70:2002;3281-3283
30. Wilson R.B., Davis D., Mitchell A.P. Rapid hypothesis testing with Candida albicans through gene disruption with short homology regions. J. Bacteriol. 181:1999;1868-1874
31. Wirsching S., Michel S., Köhler G., Morschhäuser J. Activation of the multiple drug resistance gene MDR1 in fluconazole-resistant, clinical Candida albicans strains is caused by mutations in a trans-regulatory factor. J. Bacteriol. 182:2000;400-404
32. Wirsching S., Michel S., Morschhäuser J. Targeted gene disruption in Candida albicans wild-type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates. Mol. Microbiol. 36:2000;856-865
33. Wirsching S., Moran G.P., Sullivan D.J., Coleman D.C., Morschhäuser J. MDR1-mediated drug resistance in Candida dubliniensis. Antimicrob. Agents Chemother. 45:2001;3416-3421